Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.2292
-0.0096 (-4.02%)
At close: May 13, 2025, 4:00 PM
0.2312
+0.0020 (0.87%)
Pre-market: May 14, 2025, 5:53 AM EDT

Processa Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-11.96-11.85-11.12-27.42-11.43-14.41
Upgrade
Depreciation & Amortization
0000.790.790.8
Upgrade
Other Amortization
---0.12-0.2
Upgrade
Asset Writedown & Restructuring Costs
---7.270.38.6
Upgrade
Stock-Based Compensation
0.690.631.068.833.412.73
Upgrade
Other Operating Activities
0.090.091.390.27-0.61-0.92
Upgrade
Change in Accounts Receivable
---0.070.01-0.08
Upgrade
Change in Accounts Payable
0.10.57-0.020.11-0.10.25
Upgrade
Change in Other Net Operating Assets
-0.84-0.680.620.36-1.08-0.31
Upgrade
Operating Cash Flow
-11.93-11.25-8.06-9.61-8.72-3.14
Upgrade
Capital Expenditures
-0-0-0---
Upgrade
Investing Cash Flow
-0-0-0---
Upgrade
Short-Term Debt Issued
-----0.7
Upgrade
Long-Term Debt Issued
-----0.16
Upgrade
Total Debt Issued
-----0.86
Upgrade
Long-Term Debt Repaid
--0.01----
Upgrade
Net Debt Issued (Repaid)
-0.01-0.01---0.86
Upgrade
Issuance of Common Stock
5.927.766.32-10.0517.1
Upgrade
Repurchase of Common Stock
-0.01-0.02-0.05-0.39-0.06-0.1
Upgrade
Other Financing Activities
-----0.19-
Upgrade
Financing Cash Flow
5.917.736.27-0.399.817.87
Upgrade
Net Cash Flow
-6.02-3.51-1.8-9.991.0814.72
Upgrade
Free Cash Flow
-11.93-11.25-8.07-9.61-8.72-3.14
Upgrade
Free Cash Flow Per Share
-2.47-3.68-6.15-11.93-11.38-8.38
Upgrade
Cash Interest Paid
00----
Upgrade
Levered Free Cash Flow
-6.6-5.85-4.11-2.96-4.19-0.23
Upgrade
Unlevered Free Cash Flow
-6.6-5.85-4.11-3.08-4.19-0.25
Upgrade
Change in Net Working Capital
-0.33-1.06-0.680.031.16-0.23
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q